¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"compl"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® complement ÇÑ±Û º¸Ã¼
¼³¸í   
  Ç×ü¿Í ¹ÝÀÀÇÏ¿© Ç×ü¿Í °áÇյȠ¼¼Æ÷ÀÇ ÆÄ±«¸¦ ÀÏÀ¸Å°´Â ´Ü¹éÁúÀ» ¸»ÇÑ´Ù. Ç×ü°¡ Ç×ü¿Í °áÇÕÇÑ ¼¼Æ÷¸¦ ÆÄ±«Çϴ ¹æ¹ý¿¡´Â ¿©·¯ °¡Áö°¡ Àִµ¥ ±× ÁßÀÇ Çϳª·Î Ç×ü¿Í °áÇÕÇÑ ¼¼Æ÷ÀǠǥ¸éÀ» ºÎºÐÀûÀ¸·Î ¼Õ»ó½ÃÄÑ ±× ¼¼Æ÷¸¦ ÆÄ±«Çϴ ¿ªÇÒÀ» Çϴ °ÍÀÌ ÀÌ º¸Ã¼ÀÌ´Ù. º¸Ã¼´Â 20°¡ÁöÀÇ ´Ü¹éÁú·Î ±¸¼ºµÇ¾î Àִµ¥ ¾àÀڷΠC·Î Ç¥½ÃÇϸ砰¢ Á¾·ù¸¦ ³ªÅ¸³¾ °æ¿ì¿¡´Â C¿·¿¡ ¼ýÀÚ¸¦ ½á¼­ Ç¥½ÃÇÑ´Ù.
¿µ¹® complement fixation reaction ÇÑ±Û º¸Ã¼°áÇÕ ¹ÝÀÀ, µµ¿òü°áÇÕ¹ÝÀÀ
¼³¸í   
  Ç×ü¿ÍÀÇ ¹ÝÀÀ¿¡ À־ º¸Ã¼¿Í °áÇÕÇϴ Ç×ü¸¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î, ÀÌ ¹ÝÀÀÀº ÃÖÃÊ¿¡ ±âÁöÇ׿ø, ÇǰËÇ÷û ¹× º¸Ã¼¸¦ È¥ÇÕÇÑ´Ù. Á¦2´Ü°è¿¡¼­´Â ÀûÇ÷±¸¿Í À̰Ϳ¡ ´ëÀÀÇϴ ¿ëÇ÷¼ÒÀǠȥÇÕ¾×À» °¡ÇÑ´Ù. º» ¹ÝÀÀÈÄ ¿ëÇ÷ÀÌ ÀϾÁö ¾ÊÀ¸¸é º»Ã¼´Â Ç׿øÇ×ü°áÇÕ¹°¿¡ °áÇÕÇÑ °ÍÀÌ µÇ¾î ¾ç¼ºÀÌ µÇÁö¸¸, ¿ëÇ÷ÀÌ ÀϾ °æ¿ì º¸Ã¼´Â °áÇÕÇÏÁö ¾Ê¾Æ ¼ÒºñµÇÁö ¾Ê±â ¶§¹®¿¡ À½¼ºÀÌ µÈ´Ù. º» ¹ÝÀÀÀº ±âÁöÇ÷ûÀ» ½á¼­ Ç׿ø°ËÃâ¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖÀ¸¸ç, ¸¶ÀÌÄÚÇö󽺸¶, ¸®ÄÉí, Å¬¶ó¹Ìµð¾Æ, ¹ÙÀÌ·¯½º, ¸Åµ¶ µîÀÇ Áø´Ü¿¡ ¾²ÀδÙ.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complaint
    È£¼ÒÁõ»ó
  • complement
    º¸Ã¼, µµ¿òü
  • complement activation
    º¸Ã¼È°¼ºÈ­, µµ¿òüȰ¼ºÈ­
  • complement cascade
    º¸Ã¼¿¬¼â¹ÝÀÀ, µµ¿òü¿¬¼â¹ÝÀÀ
  • complement component
    º¸Ã¼¼ººÐ, µµ¿òü¼ººÐ
  • complement fixation
    º¸Ã¼°áÇÕ
  • complement fixation inhibition test
    º¸Ã¼°áÇÕ¾ïÁ¦°Ë»ç
  • complement fixation reaction
    º¸Ã¼°áÇÕ¹ÝÀÀ
  • complement fixation test
    º¸Ã¼°áÇÕ°Ë»ç
  • complement inhibitor
    º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
  • complement mediated lysis
    º¸Ã¼¸Å°³¿ëÇØ, µµ¿òü¸Å°³¿ëÇØ
  • complement profile
    º¸Ã¼Ãø¸é»ó
  • complement receptor
    º¸Ã¼¼ö¿ëü
  • complement system
    º¸Ã¼°è, µµ¿òü°èÅë
  • complement-dependent cytotoxicity
    º¸Ã¼ÀÇÁ¸¼¼Æ÷µ¶¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complaint
    È£¼ÒÁõ»ó
  • complement
    µµ¿òü, º¸Ã¼
  • complement cascade
    µµ¿òü¿¬¼â¹ÝÀÀ, º¸Ã¼¿¬¼â¹ÝÀÀ
  • complement fixation reaction
    µµ¿òü°áÇÕ¹ÝÀÀ, º¸Ã¼°áÇÕ¹ÝÀÀ
  • complementary medicine
    º¸¿ÏÀÇÇÐ
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
  • complete hydatidiform mole
    ¿ÏÀüÆ÷»ó±âÅÂ, ¿ÏÀüÆ÷µµ¼ÛÀ̱âÅÂ
  • complete perineal tear
    ¿ÏÀüȸÀ½¿­»ó, ¿ÏÀü»ô°Áü
  • complete remission
    ¿ÏÀü¿ÏÈ­
  • complex
    º¹ÇÕ, º¹ÇÕü, ÄÞÇ÷º½º
  • complex hyperplasia
    º¹ÇÕÁõ½ÄÁõ
  • complex partial seizure
    º¹ÇպκйßÀÛ
  • compliance
    ¼øÀÀµµ, À¯¼øµµ, ź¼º
  • complication
    ÇÕº´Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complaint
    È£¼ÒÁõ»ó
  • complement
    µµ¿òü, º¸Ã¼
  • complement activation
    µµ¿òüȰ¼º, º¸Ã¼È°¼º
  • complement cascade
    º¸Ã¼¿¬¼âÁõÆø¹ÝÀÀ
  • complement component
    µµ¿òü¼ººÐ
  • complement deficiency
    µµ¿òü°áÇÌ
  • complement deficient state
    µµ¿òü°áÇÌ»óÅÂ, º¸Ã¼°áÇÌ»óÅÂ
  • complement fixation
    µµ¿òü°áÇÕ
  • complement fixation inhibition test
    º¸Ã¼°áÇÕ¾ïÁ¦½ÃÇè
  • complement fixation reaction
    º¸Ã¼°áÇÕ¹ÝÀÀ, µµ¿òü°áÇÕ¹ÝÀÀ
  • complement fixation test
    µµ¿òü°áÇÕ½ÃÇè, º¸Ã¼°áÇÕ½ÃÇè
  • complement fixation unit
    º¸Ã¼°áÇÕ´ÜÀ§
  • complement inhibitor
    º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
  • complement mediated lysis
    º¸Ã¼¸Å°³¿ëÇØ, µµ¿òü¸Å°³¿ëÇØ
  • complement profile
    µµ¿òÃ¼Ãø¸é»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complaint
    È£¼Ò ¡ìÁõ»ó(ñøßÒ)ÀÇ¡í, º´¼Ò, ¡ÈÄ.
  • complaints of patient
    ȯÀÚÀÇ È£¼Ò(ü´íº¡­û¼áÍ).
  • complement
    º¸Ã¼(ÜÍô÷), º¸Ãæ(ÜÍõö).
  • complement
    º¸Ã¼(ÜÍô÷)
  • complement
    º¸Ã¼
  • complement activation
    º¸Ã¼È°¼ºÀÛ¿ë(¡­üÀàõíÂéÄ), º¸Ã¼È°¼ºÈ­.
  • complement activation
    º¸Ã¼È°¼ºÀÛ¿ë
  • complement binding antibody
    º¸Ã¼°áÇÕÇ×ü(ÜÍô÷Ì¿ùêù÷ô÷).
  • complement cascade
    º¸Ã¼¿¬¼âÁõÆø¹ÝÀÀ
  • complement component
    º¸Ã¼¼ººÐ
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement deficiency
    º¸Ã¼°áÇÌ
  • complement deficient state
    º¸Ã¼°áÇÌ»óÅÂ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Complete inversed vitelline placenta
    ¿ÏÀü¹ÝÀü³­È²ÁÖ¸Ó´ÏŹÝ
    [¿¾ ¿ë¾î] ¿ÏÀü¹ÝÀü³­È²³¶Å¹Ý
  • Complete inversion of vitelline sac
    ¿ÏÀü³­È²ÁָӴϹÝÀü
    [¿¾ ¿ë¾î] ¿ÏÀü³­È²³¶³»Àü
  • Complex follicle
    º¹ÇÕÅÐÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] º¹ÇÕ¸ð³¶
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • complaint
    Áõ»óÈ£¼Ò
    ñøßÒû¼áÍ
  • complement
    µµ¿òü, º¸Ã¼
    µµ¿òô÷,ÜÍô÷
  • complementary opposition s.
    µµ¿òü¹Ý´ë¡ÈÄ, º¸Á·Àû¹Ý´ë¡ÈÄ
    ÜÍðëîÜÚãÓßó£ý¦
  • complete p.
    ¿ÏÀü¸¶ºñ
    èÇîïØ¦Ýö
  • complex
    º¹ÇÕ, ÄÞÇ÷º½º
    ÜÖùê
  • compliance
    ź¼º
    ÷¥àõ
  • complication
    ÇÕº´Áõ
    ùêÜ»ñø
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complete metamorphosis
    ¿ÏÀüº¯ÅÂ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complement
    º¸Ã¼(ÜÍô÷)
  • complement activation
    º¸Ã¼ Ȱ¼ºÈ­(ÜÍô÷üÀàõûù)
  • complement binding reaction
    º¸Ã¼°íÁ¤ ¹ÝÀÀ(ÜÍô÷ͳïÒÚãëë)
  • complement fixation
    º¸Ã¼°íÁ¤(ÜÍô÷ͳïÒ)
  • complement fixation inhibition test
    º¸Ã¼°íÁ¤ ÀúÇØ½ÃÇè(ÜÍô÷ͳïÒîÁúªãËúÐ)
  • complement fixation test
    º¸Ã¼°íÁ¤½ÃÇè(ÜÍô÷ͳïÒãËúÐ)
  • complement-fixing antibody
    º¸Ã¼°íÁ¤ Ç×ü(ÜÍô÷ͳïÒù÷ô÷)
  • complementarity
    »óº¸¼º(ßÓÜÍàõ)
  • complementary base pairing
    »óº¸¼º(ßÓÜÍàõ) ¿°±â(ç¤Ðñ) ¦Áþ±â
  • complementary base sequence
    »óº¸¼º ¿°±â¼­¿­(ßÓÜÍàõç¤ÐñßíÖª)
  • complementary DNA
    »óº¸¼º(ßÓÜÍàõ) DNA
  • complementary genes
    »óº¸¼º À¯ÀüÀÚ(ßÓÜÍàõë¶îîí­)
  • complementary interaction
    »óº¸¼º »óÈ£ÀÛ¿ë(ßÓÜÍàõßÓû»íÂéÄ)
  • complementary RNA
    »óº¸¼º(ßÓÜÍàõ) RNA
  • complementary strand
    »óº¸¼º(ßÓÜÍàõ) °¡´Ú
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • complaint
    È£¼Ò, º´¼Ò, ¡ÈÄ
  • complement
    º¸Ã¼, º¸Ãæ
  • complement fixation test
    º¸Ã¼°áÇÕ½ÃÇè
  • complementarity
    »óº¸¼º, º¸Ã¼¼º
  • complete
    ¿ÏÀüÇÑ
  • complex
    ÄÝÇ÷º½º, º¹ÇÕü
  • complex echo pattern
    º¹ÇÕ¿¡ÄÚ¾ç»ó
  • complex potential
    º¹ÇÕÀüÀ§
  • complicate
    º¹ÀâÇÑ, ÂøÀâÇÑ, ÇÕº´, º´¹ß
  • complication
    ÇÕº´Áõ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
compl complaint; complete, completed, completion; complication, complicated
complic complication, complicated
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
complex C complex
Complex I complex
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • JrId: 3131
    JournalTitle: Complement (Basel, Switzerland)
    MedAbbr: Complement
    ISSN: 0253-5076
    ESSN:
    IsoAbbr: Complement
    NlmId: 8409977
  • JrId: 3140
    JournalTitle: Complement and inflammation.
    MedAbbr: Complement Inflamm
    ISSN: 1012-8204
    ESSN:
    IsoAbbr:
    NlmId: 8903074
  • JrId: 20796
    JournalTitle: Complementary therapies in nursing & midwifery.
    MedAbbr: Complement Ther Nurs Midwifery
    ISSN: 1353-6117
    ESSN:
    IsoAbbr:
    NlmId: 9506953
  • JrId: 21096
    JournalTitle: Complementary therapies in medicine.
    MedAbbr: Complement Ther Med
    ISSN: 0965-2299
    ESSN:
    IsoAbbr:
    NlmId: 9308777
  • JrId: 22893
    JournalTitle: Complicated Cardiac Patient.
    MedAbbr: Complicat Card Patient
    ISSN: 0888-3777
    ESSN:
    IsoAbbr:
    NlmId: 9883043
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • O03.7
    Complete or unspecified, complicated by embolism
    »öÀüÁõ¿¡ ÀÇÇØ ÇÕº´µÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
  • O04.7
    Complete or unspecified, complicated by embolism
    »öÀüÁõ¿¡ ÀÇÇØ ÇÕº´µÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
  • O05.7
    Complete or unspecified, complicated by embolism
    »öÀüÁõ¿¡ ÀÇÇØ ÇÕº´µÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
  • O06.7
    Complete or unspecified, complicated by embolism
    »öÀüÁõ¿¡ ÀÇÇØ ÇÕº´µÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
  • O03.5
    Complete or unspecified, complicated by genital tract and pelvic infection
    »ý½Ä·Î ¹× °ñ¹Ý°¨¿°¿¡ ÀÇÇØ ÇÕº´µÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • complaint
    È£¼Ò, º´¼Ò, ¡ÈÄ
  • complement activation
    º¸Ã¼ Ȱ¼º ÀÛ¿ë, º¸Ã¼ Ȱ¼ºÈ­
  • complement consumption test
    º¸Ã¼ ¼Òºñ ½ÃÇè
  • complement fixation inhibition test
    º¸Ã¼ °íÁ¤ ÀúÇØ ½ÃÇè
  • complement fixation test
    º¸Ã¼ °áÇÕ ½ÃÇè, º¸Ã¼ °áÇÕ °Ë»ç, º¸Ã¼ °íÁ¤ °Ë»ç
  • complement fixing antibody
    º¸Ã¼ °áÇÕ Ç×ü
  • complement splitting
    º¸Ã¼ ºÐÇØ
  • complement-mediated cytotoxicity
    º¸Ã¼ ¸Å°³¼º ¼¼Æ÷ µ¶¼º
  • complementarity
    »óº¸¼º, º¸Ã¼¼º
  • complementary afterimage
    º¸»ö ÀÜ»ó
  • complementary base pair
    »óº¸¼º ¿°±â½Ö
  • complementary factor
    º¸Ãæ ÀÎÀÚ
  • complementary male
    º¸¿õ
  • complementation
    »óº¸, »óº¸¼º, º¸»ó
    À¯ÀüÇп¡¼­´Â µ¿ÀÏ ¿°»öü»óÀÇ ºÐ¸íÇÑ 2°³ÀÇ µ¹¿¬º¯ÀÌ °á°ú ¾ß»ýÇü ±â´ÉÀÌ ÀçÇöµÇ´Â °Í. ¹ÙÀÌ·¯½ºÇп¡¼­´Â ÀϺΠ¼¼±ÕÀÇ È¥ÇÕ °¨¿° ½Ã¿¡ 2°³ÀÇ °á¼Õ ¹ÚÅ׸®¿ÀÆäÀÌÁöÀÇ »óÈ£ ÀÛ¿ëÀ¸·Î µÑÀÇ º¹Á¦°¡ ³ªÅ¸³ª´Â °Í.
  • complete abortion
    ¿ÏÀü À¯»ê
    ¼öÅ »ê¹° ¸ðµÎ°¡ Àڱÿ¡¼­ ¹èÃâµÇ¾ú´Ù°í È®ÀÎµÈ À¯»ê.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
complaint A disorder, disease, or symptom, or the description of it.
Origin: O. Fr. Complainte, fr. L. Complango, to lament
(05 Mar 2000)
complement <immunology> A term originally used to refer to the heat labile factor in serum that causes immune cytolysis, the lysis of antibody coated cells and now referring to the entire functionally related system comprising at least 20 distinct serum proteins that is the effector not only of immune cytolysis but also of other biologic functions.
Complement activation occurs by two different sequences, the classic and alternative pathways. The proteins of the classic pathway are termed components of complement and are designated by the symbols C1 through C9.
C1 is a calcium dependent complex of three distinct proteins C1q, C1r and C1s. The proteins of the alternative pathway (collectively referred to as the properdin system) and complement regulatory proteins are known by semisystematic or trivial names. Fragments resulting from proteolytic cleavage of complement proteins are designated with lower case letter suffixes, for example, C3a. Inactivated fragments may be designated with the suffix i, for example C3bi. Activated components or complexes with biological activity are designated by a bar over the symbol for example C1 or C4b, 2a.
The classic pathway is activated by the binding of C1 to classic pathway activators, primarily antigen-antibody complexes containing IgM, IgG1, IgG3, C1q binds to a single IgM molecule or two adjacent IgG molecules.
The alternative pathway can be activated by IgA immune complexes and also by nonimmunologic materials including bacterial endotoxins, microbial polysaccharides and cell walls. Activation of the classic pathway triggers an enzymatic cascade involving C1, C4, C2 and C3, activation of the alternative pathway triggers a cascade involving C3 and factors B, D and P. Both result in the cleavage of C5 and the formation of the membrane attack complex.
Complement activation also results in the formation of many biologically active complement fragments that act as anaphylatoxins, opsonins or chemotactic factors.
(05 Jan 1998)
complement 1 The first complement component to act in the cytolysis reaction. It is a trimolecular complex held together with ca ions and when activated, has esterase activity which initiates the next step in the sequence.
(12 Dec 1998)
complement 1 inactivators Compounds which inhibit, antagonise, or inactivate complement 1. A well-known inhibitor is a serum glycoprotein believed to be alpha-2-neuroaminoglycoprotein. It inhibits the activated (esterase) form of complement 1 as well as kinin-forming, coagulation, and fibrinolytic systems. Deficiency of this inactivator has been found in patients with hereditary angioneurotic oedema. These compounds are members of the serpin superfamily.
(12 Dec 1998)
complement 1q <chemical> Subcomponent of complement 1 (c1) which recognises and binds to the heavy chain of IgG or IgM initiating the classical complement pathway. The interaction of c1q and immunoglobulin activates c1r and c1s. The activated c1r and c1s molecules are cleaved off the complex by c1-inhibitor, allowing the collagen-like region of c1q to become accessible for interaction with cell membrane c1q receptors.
Chemical name: Complement C1q
(12 Dec 1998)
complement 1r <enzyme> Subcomponent of complement 1 which, when activated by c1q, activates subcomponent c1s by proteolytic cleavage.
Registry number: EC 3.4.21.41
(12 Dec 1998)
complement 1s <enzyme> The activated form of complement 1 which has hydrolase activity. In the classical pathway, it splits first c4 and then c2 into active components, thereby generating a new enzyme referred to as eac142 or c42 or c3 convertase.
Registry number: EC 3.4.21.42
(12 Dec 1998)
complement 2 The third component in the complement reaction sequence. It is a beta-globulin with a molecular weight of 117,000, a serum concentration of 30 micrograms/ml and a sedimentation coefficient of 4. It activates c3.
(12 Dec 1998)
complement 3 The fourth component to attach in the complement reaction sequence. It is a beta-globulin with a sedimentation coefficient of 5.5, a molecular weight of 185,000 and a serum concentration of 1.3 micrograms/ml. Its fragments have anaphylatoxic, chemotactic, and histaminic action and affect smooth muscle.
(12 Dec 1998)
complement 3 convertase <enzyme> The enzyme which in both the classical and alternate complement pathways cleaves complement 3 into anaphylatoxin (c3a) and c3b.
Registry number: EC 3.4.21.43
(12 Dec 1998)
complement 3 nephritic factor A magnesium-dependent IgG autoantibody found in serum of patients with chronic mesangioproliferative hypocomplementemic glomerulonephritis. It causes inactivation of c3 in the alternate pathway by cleaving c3 into two inactive fragments, c3c and c3d, instead of the normal c3b.
(12 Dec 1998)
complement 3a <chemical> Smaller fragment formed when c3 convertase splits c3 into c3a and c3b. C3a is a 77-amino acid peptide that includes a carboxy-terminal arginine which is crucial for its biological activities. C3a causes symptoms of immediate hypersensitivity (anaphylaxis) including smooth muscle contraction, mast cell histamine release, and local inflammation. It is considered an anaphylatoxin along with c4a, c5a, and c5a des-arginine.
Chemical name: Complement C3a
(12 Dec 1998)
complement 3b <chemical> The larger fragment formed when c3 convertase splits c3 into c3a and c3b. In both the classical and alternate pathway, c3b participates in immune adherence and enhances phagocytosis. It also forms a cellular intermediate which continues the complement process. In the alternate pathways, c3b initiates a positive feedback activation of c3pase.
Chemical name: Complement C3b
(12 Dec 1998)
complement 3b inactivators Compounds which inhibit, antagonise, or inactivate complement 3b. A well-known inhibitor is a beta-globulin which cleaves c3b into inactive fragments c3c and c3d. C3bina plays a key role in the regulation of the complement system by blocking the cytolytic sequence and preventing recruitment of the properdin amplification loop.
(12 Dec 1998)
complement 3c <chemical> An inactivated form of complement 3b (c3b). Complement 3b is inactivated with the help of two regulatory factors, complement factor h and complement factor I. Complement factor h (c3b inactivator accelerator) makes c3b susceptible to the serine protease, complement factor I (formerly called kaf, c3binf, or enzyme 3b inactivator), to form ic3b. Then complement factor I and a trypsin-like proteolytic enzyme further cleave ic3b into c3c and c3dg.
Chemical name: Complement C3c
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 1
  • Complement Activating Enzymes - »õâ Enzymes that activate one or more COMPLEMENT PROTEINS in the complement system leading to the formation of the COMPLEMENT MEMBRANE ATTACK COMPLEX, an important response in host defense. They are enzymes in the various COMPLEMENT ACTIVATION pathways.
    Synonyms : Activating Enzymes, Complement, Enzymes, Complement Activating
  • Complement Activation - »õâ The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES.
    Synonyms : Activation, Complement, Activations, Complement, Complement Activations
  • Complement C1 - »õâ The first complement component to act in the activation of CLASSICAL COMPLEMENT PATHWAY. It is a calcium-dependent trimolecular complex made up of three subcomponents: COMPLEMENT C1Q; COMPLEMENT C1R; and COMPLEMENT C1S at 1:2:2 ratios. When the intact C1 binds to at least two antibodies (involving C1q), C1r and C1s are sequentially activated, leading to subsequent steps in the cascade of COMPLEMENT ACTIVATION.
    Synonyms : C1 Complement, Complement 1, Complement Component 1, C1, Complement, Complement, C1, Component 1, Complement
  • Complement C1 Inactivator Proteins - »õâ Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits.
    Synonyms : C1 Esterase Inhibitor, Complement 1 Esterase Inhibitors, Complement C1 Inactivating Proteins, Complement C1 Inhibiting Proteins, Complement C1 Inhibitor Proteins, Complement C1r Protease Inhibitor Proteins, Complement C1s Esterase Inhibitor Proteins
  • Complement C1 Inhibitor Protein - »õâ An endogenous serine protease inhibitor (SERPINS). It is a 105-kDA plasma glycoprotein, encoded by C1NH gene and produced primarily by the liver and monocytes. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from hereditary ANGIONEUROTIC EDEMA.
    Synonyms : C1-INH Protein, C1-Inhibitor Protein, Complement C1-Inhibitor Protein, Plasma Protease C1 Inhibitor, C1 INH Protein, C1 Inhibitor Protein, Protein, C1-INH, Protein, C1-Inhibitor, Protein, Complement C1-Inhibitor
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 2 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 3 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
º¹ÇÕÇïÆÄ¿¬Áúݼ¿ - »õâ
Àϵ¿Á¦¾à
Ascorbic Acid, Nicotinamide, Tocopherol Acetate, Ursodesoxycholic Acid
ÀϹÝÀǾàǰ | ¹Ì»ý»ê
º¹ÇÕǪ¸µ°¡¿Ãݼ¿ - »õâ
µå¸²ÆÄ¸¶
Ascorbic Acid granule, Phenylpropanolamine HCl S.R.
ÀϹÝÀǾàǰ | »èÁ¦
º¹ÇÕ¶ó¶ó¼Õ¿¬°í - »õâ
´ºÁ¨ÆÊ
A13300881 Centella asiatica Extract, Hydrocortisone acetate, Neomycin Sulfate
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
complementary medicine the practice of medicine that combines traditional medicine with alternative medicine
Ãâó: wordnet.princeton.edu/perl/webwn
complementation the grammatical relation of a word or phrase to a predicate complementary distribution: (linguistics) a distribution of related speech sounds or forms in such a way that they only appear in different contexts
Ãâó: wordnet.princeton.edu/perl/webwn
complement fixation an immune response in which an antigen-antibody combination inactivates a complement (so it is unavailable to participate in a second antigen-antibody combination)
Ãâó: wordnet.princeton.edu/perl/webwn
complemental acting as or providing a complement (something that completes the whole)
Ãâó: wordnet.princeton.edu/perl/webwn
complementarity a relation between two opposite states or principles that together exhaust the possibilities the interrelation of reciprocity whereby one thing supplements or depends on the other; "the complementarity of the sexes"
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • compl.
    complement;complete(d)
  • complacence
    ¾È½É
  • complacence,-cency
    Àڱ⸸Á·;¸¸Á·À» ÁÖ´Â °Í
  • complacency
    Àڱ⸸Á·
  • complacent
    ±â»µÇϰí ÀÖ´Â; »ó³ÉÇÑ
  • complacent
    Àڱ⠸¸Á·ÀÇ;¸¶À½¿¡ ÈíÁ·ÇÑ;~ly
  • complain
    ºÒÆòÇÏ´Ù
  • complain
    ºÒÆòÇÏ´Ù;Åõ´ú°Å¸®´Ù;ºÒ¸¸À» Åоî³õ´Ù;Ǫ³äÇÏ´Ù;ÇÑźÇÏ´Ù;Çϼҿ¬ÇÏ´Ù;(Á¤½ÄÀ¸·Î)°í¼ÒÇÏ´Ù;(º´°í.°íÅëÀ»)È£¼ÒÇÏ´Ù;¾Î´Ù;½½Ç ¼Ò¸®¸¦ ³»´Ù;½ÅÀ½ÇÏ´Ù;~er ºÒÆò°¡
  • complainant
    ºÒÆòÀ» ¸»ÇÏ´Â »ç¶÷
  • complainant
    ¿ø°í;°í¼ÒÀÎ;ºÒÆòÇÏ´Â »ç¶÷
  • complainingly
    ºÒÆòÇϸç;Åõ´ú°Å¸®¸ç;ºÒ¸¸½º·¹
  • complaint
    ºÒÆò
  • complaint
    ºÒÆò;ºÒ¸¸;Ǫ³ä;Åõ´ú°Å¸²;ºÒÆò°Å¸®;°í¼Ò;(¹Î»ç¼Ò¼Û¿¡¼­)¿ø°íÀÇ Ã¹ Áø¼ú;º´
  • complaisance
    °ø¼ÕÇÔ
  • complaisance
    Á¤Áß;°ø¼Õ;»ó³ÉÇÔ;À¯¼øÇÔ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
compl the feeling you have when you are satisfied with yourself
compl the feeling you have when you are satisfied with yourself
compl contented to a fault
compl in a self-satisfied manner
compl make a formal accusation
compl express complaints, discontent, displeasure, or unhappiness
compl a person who brings an action in a court of law
compl a person given to excessive complaints and crying and whining
compl expressing pain or dissatisfaction of resentment
compl with complaints
compl (criminal law) a pleading describing some wrong or offense
compl (civil law) the first pleading of the plaintiff setting out the facts on which the claim for relief is based
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 1
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á